Publications

Newsroom

Twitter

Videos

Photos

20160128 EGA Regulatory and Scientific Affairs Conferenc

Position Paper. Incentives Review The Orphan and Paediatric Incentives

1 March 2021

Policy

Open

Electronic product information: from principles to actions. AESGP, EFPIA and Medicines for Europe reflections on EMAHMA – EC Key principles for electronic product information

10 February 2021

Report

Open

Biosimilars in the EU – Information guide for healthcare professionals – unofficial Ukrainian translation now available

8 February 2021

External Resource

OPEN UNOFFICIAL UKRAINIAN TRANSLATION

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Report

Open

Filling the gap: How off-patent medicines can improve the equity and quality of cancer care

4 February 2021

Factsheet

Open

The total clinical experience with biosimilar medicines exceeds 2 billion patient treatment days

16 December 2020

Infographic

Open

Biosimilar medicines are available in therapy areas which represent 65% of the biologics market by value

16 December 2020

Infographic

Open

In Europe, biosimilar medicines have captured 7% more of the biologics market over a 5-year period

16 December 2020

Infographic

Open

Growing number of biologic therapies offers future opportunities for biosimilar development

16 December 2020

Infographic

Open

White Paper: Anatomy of a failure to launch: A review of barriers to generic and biosimilar market entry and the use of competition law as a remedy

5 November 2020

Report

Read more

Subscribe to our newsletter